Stockwinners Market Radar for January 17, 2022 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service

20:11 EST Fly Intel: Top five weekend stock stories - Catch up on the weekend's top five stories with this list compiled by The Fly: 1. Unilever (UN, UL) confirms approach made to GlaxoSmithKline (GSK) and Pfizer (PFE) about GSK Consumer Healthcare. The company said that, "Unilever notes recent reporting regarding its interest in GSK Consumer Healthcare and confirms that it has approached GSK and Pfizer about a potential acquisition of the business. GSK Consumer Healthcare is a leader in the attractive consumer health space and would be a strong strategic fit as Unilever continues to re-shape its portfolio. There can be no certainty that any agreement will be reached." Meanwhile, GlaxoSmithKline has also said in a statement that, "GlaxoSmithKline today confirms that it has received three unsolicited, conditional and non-binding proposals from Unilever plc to acquire the GSK Consumer Healthcare business. The latest proposal received on 20th December 2021 was for a total acquisition value of GBP 50 billion comprising GBP 41.7 billion in cash and GBP 8.3 billion in Unilever shares. The Consumer Healthcare business is a Joint Venture between GSK and Pfizer, with GSK holding a majority controlling interest of 68% and Pfizer 32%. GSK rejected all three proposals made on the basis that they fundamentally undervalued the Consumer Healthcare business and its future prospects." 2. The chief executives of major U.S. passenger and cargo carriers on Monday warned of an impending "catastrophic" aviation crisis on Wednesday when AT&T (T) and Verizon (VZ) are set to deploy new 5G service, Reuters' David Shepardson reported. The airlines warned the new C-Band 5G service could potentially make a significant number of widebody aircraft unusable and "could potentially strand tens of thousands of Americans overseas." "Unless our major hubs are cleared to fly, the vast majority of the traveling and shipping public will essentially be grounded," wrote the chief executives of American Airlines (AAL), Delta Air Lines (DAL), United Airlines (UAL), Southwest Airlines (LUV) and others. 3. Revenue for Angi's (ANGI) ads and leads business was flat in the latest quarter, even as demand for contractors surged, and the stock is down 33% over the past 12 months, Nicholas Jasinski wrote in this week's edition of Barron's. But Angi is working on a fix and the stock now looks like a bargain, the author contended. So far, investors aren't paying attention, with Angi stock trading for just 1.8 times the $2.29 billion in revenue that Wall Street expects the company to generate in 2023, the publication pointed out. That compares with Angi's five-year average of more than five times year-ahead revenue. Leading online marketplaces like Airbnb (ABNB), Etsy (ETSY), and Uber Technologies (UBER) fetch an average multiple of 6.1, Jasinski added. 4. ViacomCBS (VIAC) subsidiary Paramount Pictures' "Scream" won the Martin Luther King Jr. holiday weekend at the box office with a four-day gross of $34M. For the three-day domestic weekend, the movie earned an estimated $31M from 3,664 locations. Overseas, the slasher pic grossed $18M from 50 markets for a global cume of $52M. 5. Freeport-McMoRan (FCX), Take-Two (TTWO), and Shell (RDS.A) saw positive mentions in this week's edition of Barron's.

14:22 EST Spirit Airlines appoints Linde Grindle as Chief Human Resources Officer - Spirit Airlines announced the appointment of Linde Grindle to the position of Chief Human Resources Officer. As CHRO, Grindle will report directly to Spirit Airlines President and Chief Executive Officer Ted Christie, and she will oversee Spirit's Human Resources department using her expertise to help attract, develop, and retain top talent while strengthening Spirit's culture and driving engagement across the airline.

14:11 EST Enhertu granted priority review in HER2-positive metastatic breast cancer - AstraZeneca and Daiichi Sankyo have received notification of acceptance of the supplemental Biologics License Application of Enhertu for the treatment of adult patients in the U.S. with unresectable or metastatic HER2-positive breast cancer who have received a prior anti-HER2-based regimen. The application has also been granted Priority Review. Enhertu is a HER2-directed antibody drug conjugate being jointly developed by AstraZeneca and Daiichi Sankyo.

14:03 EST Check Point report shows DHL most imitated brand in phishing attempts in Q4 - Check Point Research, the Threat Intelligence arm of Check Point Software (CHKP), has published its new Brand Phishing Report for Q4 2021. The report highlights the brands which were most frequently imitated by criminals in their attempts to steal individuals' personal information or payment credentials during October, November and December. For the first time, DHL (DPSGY) took the number one spot in Q4, replacing Microsoft (MSFT) as the brand most likely to be targeted by cybercriminals in phishing scams. Twenty-three percent of all brand phishing attempts were related to the global logistics and shipping company, up from just 9% in Q3, as threat actors sought to take advantage of vulnerable online consumers during the busiest retail period of the year. Microsoft, which yet again led the rankings in Q3 by accounting for 29% of all phishing attempts, only accounted for 20% of phishing scams in Q4. FedEx (FDX) also appeared in the top ten list for the first time in Q4 2021. The Q4 report also reinforces an emerging trend from Q3, with social media seeming to solidify its position among the top three sectors imitated in phishing attempts. While Facebook (FB) has dropped out of the top ten brands most likely to be imitated, WhatsApp has moved from 6th position to 3rd, now accounting for 11% of all phishing attempts. LinkedIn has moved from 8th position to 5th, now accounting for 8% of all phishing related attacks.

11:11 EST Credit Suisse Chairman Horta-Osorio resigns after board investigation - Credit Suisse announced that its board has appointed Axel Lehmann as the bank's new Chairman effective immediately. He succeeds Antonio Horta-Osorio, who resigned following an investigation commissioned by the board. Severin Schwan, Vice-Chairman and Lead Independent Director of the Board of Credit Suisse, said: "We respect Antonio's decision and owe him considerable thanks for his leadership in defining the new strategy, which we will continue to implement over the coming months and years. Axel Lehmann as the new Chairman, with his extensive international and Swiss industry experience, is ideally suited to drive forward the strategic and cultural transformation of the bank. We wish Axel every success in his new role and Antonio all the best for the future." Following his appointment by the board, Axel Lehmann has taken office as Chairman. The board will also propose him for election as Chairman at the upcoming annual general meeting on April 29. Reference Link